Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo. - Wikidata - awgldk - TriplyDB

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

http://www.wikidata.org/entity/Q34362849

about

Regulation of mammalian transcription and splicing by Nuclear RNAi Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.The role of antisense long noncoding RNA in small RNA-triggered gene activation.Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver.Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells Treatment of Liver Cancer by C/EBPA saRNA.FXR-Gankyrin axis is involved in development of pediatric liver cancer.Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.Emerging cancer-specific therapeutic aptamers.Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA.miRNA-Mediated RNA Activation in Mammalian Cells.Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy.Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery.Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.Tumour promotion versus tumour suppression in chronic hepatic iron overload.Small RNA-Guided Transcriptional Gene Activation (RNAa) in Mammalian Cells.Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.RNA activation technique and its applications in cancer research.Molecular engineering of dendrimer nanovectors for siRNA delivery and gene silencing Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection

P2860

Q26776412-383BF81F-B901-4A92-A77F-6A528028B9DB Q28085438-E748C958-F3C1-44E2-99E5-5CC283181F92 Q28542378-6B5F7FE1-3F1C-42EC-B791-B87BBD345D4A Q34515078-A46854B5-BD61-4009-A0A2-3D4AF49F7D3E Q34518484-153D550B-FE9B-4DAA-944A-EFAE50B3AC56 Q34521048-F0A528D0-37F3-462C-B980-17C1D7AA0EDF Q34547200-CC2D70E4-4DA8-4C7D-A010-EF1B4F09CF3B Q35683220-67C4485C-B071-482B-819D-2C35A8736411 Q35705414-91675B87-1E6E-4699-B1D0-91D69C258146 Q36702382-6924871C-A4E6-49E0-8FFF-707FFCD3A66A Q38287891-12837A2E-CFE4-4973-B240-87B0F539A990 Q38768973-2174F10A-ECE3-4C43-AF0D-E5598D8C5BB1 Q38860419-A1BFF19D-9254-42E3-BF49-6DC267910475 Q39306735-90EA01C6-DB4C-426A-8E73-05ACE17A7575 Q39425770-7F55A86C-9D65-4149-B38D-BC4D34D93D2B Q40150095-0354B3E0-06A7-4145-803D-6DE58B984FD6 Q40150106-A1F0C7C4-BB58-4FF5-B495-E653789EE624 Q40485794-ADC061F6-750B-4429-A234-8E5DC9D2CC69 Q47145170-7E661411-9140-493D-BF99-062C3B5D4E65 Q47565545-90293799-D631-4DED-A773-5B971E76C549 Q47569463-8D7C02ED-E7C8-4875-B10C-3ABE6DF7CA98 Q48080954-A9AA28F8-846B-479F-BE08-23337E4535B9 Q50930184-F682D552-88E3-4598-AB27-7C38BDBB9795 Q51743701-02F24236-CDE7-441F-8E24-64116DA00E2C Q55337892-AAABEC9E-B1BC-49ED-92D4-2531F966D029 Q58215323-F537877E-8A0B-48AC-896C-FA21CD151351 Q58759051-986252A5-90FF-4E85-8FE1-4A6F0A36FC02

P2860

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

http://www.wikidata.org/entity/Q34362849

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@ast

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@en

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@nl

type

label

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@ast

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@en

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@nl

prefLabel

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@ast

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@en

Novel RNA oligonucleotide impr ...... liver carcinogenesis in vivo.

@nl

P1433

Q34362849-74E3665C-024A-4414-A884-714EA823F9EA

P1476

Q34362849-0E3FA943-5251-4D68-92D9-AA5BCC008D25

P2093

Q34362849-00A2C6D1-4B67-40D4-806E-420F739720EB

Q34362849-0288A2AB-F782-4BC0-A726-BDB5EC3E53CC

Q34362849-04E686B3-33A6-4513-A14C-F35577A08E30

Q34362849-05CB46B1-EFF9-4ED4-A292-61BE237FD6D3

Q34362849-0EC61A2A-507D-4573-9772-E5F997B77475

Q34362849-1D064332-9DCA-4321-AE23-5938E48A83A8

Q34362849-2D65986F-3582-4A56-BFD2-EEC3982F20B2

Q34362849-331475C5-149F-4509-B19B-FA4F6250867C

Q34362849-51F4F02C-FCC7-4F06-BC75-9B3326968B2A

Q34362849-6641F953-A528-428B-BF03-A3E0C79CCDC7

P2860

Q34362849-035ECA6E-5F56-4DAA-8D46-C0746FD41619

Q34362849-05B0FBF4-F9BB-4B5F-82E1-C81D34F6722F

Q34362849-0961BFA9-EDAF-4D75-8AAD-9B80CFE68660

Q34362849-0BB77189-FFA1-4686-8733-A83289248D85

Q34362849-0F2B820E-B378-439F-B9C4-FCC64941F687

Q34362849-11D66131-DE2A-4EA8-AF60-02C4FB2F3CDA

Q34362849-1205556F-A562-46A6-ABA0-F1B4910CA769

Q34362849-206C6F4B-2D85-430C-834F-A626178E9E34

Q34362849-23CD783A-9761-479B-92B2-C3D5176B92F0

Q34362849-30BF22C0-A027-4F10-842E-35AFE5C976CB

P304

Q34362849-63B32BA3-A386-4C2D-A92E-BE3DEBB77E1E

P31

Q34362849-FAC14E25-D9A6-4790-B740-79CD575E0DD2

P356

Q34362849-895B537A-20F1-4248-BC05-7FD521C24335

P407

Q34362849-F93504E5-6459-4292-B8CA-5257FAA717BC

P433

Q34362849-8B17F20C-F8C9-4AFF-B13D-4CCECA80D031

P478

Q34362849-42FF2480-40CC-4ACD-A018-2FF244257CE0

P50

Q34362849-3244B99F-E393-4F20-B626-1C9C20A95D3E

Q34362849-3BBD0E9D-2EFD-4300-97D7-47D38DE1245E

Q34362849-810C3615-B9E5-4383-8027-6F79F04B7E4E

P577

Q34362849-D7E20F23-6512-4C33-8F54-7E90C30E3304

P5875

Q34362849-8BF330CC-4A23-4C7D-A2B1-CC3656B212EC

P698

Q34362849-016AE788-B740-4A95-B713-42AC23A58657

P932

Q34362849-3AA933EE-31CC-4A0C-BDB3-9A05DB528C54

P356

P1433

P1476

Novel RNA oligonucleotide impr ...... s liver carcinogenesis in vivo

@en

P2093

Abdelali Haoudi

http://www.w3.org/2001/XMLSchema#string

Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Dimitris Zacharoulis

http://www.w3.org/2001/XMLSchema#string

Donald A Tomalia

http://www.w3.org/2001/XMLSchema#string

Duncan R Spalding

http://www.w3.org/2001/XMLSchema#string

Joanna P Nicholls

http://www.w3.org/2001/XMLSchema#string

John J Rossi

http://www.w3.org/2001/XMLSchema#string

Long R Jiao

http://www.w3.org/2001/XMLSchema#string

Madhava Pai

http://www.w3.org/2001/XMLSchema#string

Malkhaz Mizandari

http://www.w3.org/2001/XMLSchema#string

P2860

DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

The promises and pitfalls of RNA-interference-based therapeutics

Small dsRNAs induce transcriptional activation in human cells

C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4

IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression.

P304

216-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26669

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255715928

http://www.w3.org/2001/XMLSchema#string

P698

23929703

http://www.w3.org/2001/XMLSchema#string

P932

4655108

http://www.w3.org/2001/XMLSchema#string